Trgovina ADMA Biologics, Inc. - ADMA CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Pogoji trgovanja
| Razmik | 0.0304 | ||||||||
|
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.024068% | ||||||||
|
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.001846% | ||||||||
| Čas nočne pristojbine | 21:00 (UTC) | ||||||||
| Min. tržena količina | 1 | ||||||||
| Valuta | USD | ||||||||
| Kritje | 20% | ||||||||
| Borza | United States of America | ||||||||
| Provizija na trgovanje | 0% |
*Information provided by Capital.com
Ključni statistični podatki
| Predhodno. Zapri* | 3.1105 |
| Odpri* | 3.3797 |
| Enoletna sprememba* | 134.7% |
| Dnevni razpon* | 3.27 - 3.3797 |
| Razpon 52 wk | 1.43-3.98 |
| Povprečni obseg (10 dni) | 3.40M |
| Povprečni obseg (3 meseci) | 50.84M |
| Tržna kapitalizacija | 722.95M |
| Razmerje P/E | -100.00K |
| Število delnic v obtoku | 222.16M |
| Prihodki | 130.48M |
| EPS | -0.37 |
| Dividenda (donosnost v %) | N/A |
| Beta | 0.93 |
| Datum naslednjega zaslužka | May 9, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
|---|---|---|---|---|---|---|
| Mar 24, 2023 | 3.3198 | 0.0299 | 0.91% | 3.2899 | 3.4096 | 3.2301 |
| Mar 23, 2023 | 3.1105 | 0.0997 | 3.31% | 3.0108 | 3.1204 | 3.0107 |
| Mar 22, 2023 | 2.9809 | -0.0697 | -2.28% | 3.0506 | 3.0905 | 2.9809 |
| Mar 21, 2023 | 3.0706 | 0.0300 | 0.99% | 3.0406 | 3.1703 | 3.0406 |
| Mar 20, 2023 | 3.0507 | -0.0299 | -0.97% | 3.0806 | 3.1005 | 2.9310 |
| Mar 17, 2023 | 3.0606 | -0.0298 | -0.96% | 3.0904 | 3.1204 | 3.0207 |
| Mar 16, 2023 | 3.1105 | 0.0300 | 0.97% | 3.0805 | 3.1703 | 3.0506 |
| Mar 15, 2023 | 3.1105 | 0.0001 | 0.00% | 3.1104 | 3.1902 | 3.0806 |
| Mar 14, 2023 | 3.2002 | -0.0099 | -0.31% | 3.2101 | 3.2600 | 3.1603 |
| Mar 13, 2023 | 3.1803 | 0.1696 | 5.63% | 3.0107 | 3.2201 | 3.0008 |
| Mar 10, 2023 | 3.0806 | -0.1594 | -4.92% | 3.2400 | 3.2600 | 3.0307 |
| Mar 9, 2023 | 3.2600 | -0.1496 | -4.39% | 3.4096 | 3.4395 | 3.2102 |
| Mar 8, 2023 | 3.3896 | 0.0100 | 0.30% | 3.3796 | 3.4495 | 3.3497 |
| Mar 7, 2023 | 3.3797 | 0.0200 | 0.60% | 3.3597 | 3.4495 | 3.2998 |
| Mar 6, 2023 | 3.3398 | -0.0697 | -2.04% | 3.4095 | 3.4295 | 3.2999 |
| Mar 3, 2023 | 3.3996 | -0.0897 | -2.57% | 3.4893 | 3.4893 | 3.3697 |
| Mar 2, 2023 | 3.4395 | -0.0698 | -1.99% | 3.5093 | 3.5392 | 3.4395 |
| Mar 1, 2023 | 3.5292 | -0.0099 | -0.28% | 3.5391 | 3.6489 | 3.5292 |
| Feb 28, 2023 | 3.5392 | 0.0798 | 2.31% | 3.4594 | 3.5890 | 3.4594 |
| Feb 27, 2023 | 3.4694 | 0.0599 | 1.76% | 3.4095 | 3.5192 | 3.3996 |
ADMA Biologics, Inc. Events
| Čas (UTC) (UTC) | Država | Dogodek |
|---|---|---|
| No events scheduled | ||
- Letni
- Četrtletno
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Skupni prihodki | 80.9426 | 42.2198 | 29.3491 | 16.9853 | 22.7606 |
| Prihodki | 80.9426 | 42.2198 | 29.3491 | 16.9853 | 22.7606 |
| Celotni stroški prihodkov | 79.7693 | 61.2914 | 39.5042 | 42.1946 | 29.1643 |
| Bruto dobiček | 1.17329 | -19.0716 | -10.1552 | -25.2094 | -6.40376 |
| Celotni odhodki iz poslovanja | 139.316 | 106.143 | 80.7359 | 77.2742 | 63.2808 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 55.1856 | 39.2209 | 28.0804 | 30.3085 | 24.5966 |
| Raziskave in razvoj | 3.64606 | 5.90701 | 2.34385 | 3.92612 | 6.22959 |
| Nenavadni odhodki (prihodki) | 0 | -0.9918 | 9.9625 | 0 | 2.05561 |
| Prihodki iz poslovanja | -58.3737 | -63.9231 | -51.3868 | -60.2889 | -40.5202 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -13.0223 | -11.6969 | -8.19259 | -5.32738 | -3.22862 |
| Drugo, neto | -0.25158 | -0.12853 | -0.22732 | -0.12712 | -0.01014 |
| Čisti dobiček pred obdavčitvijo | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
| Čisti dobiček po davkih | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
| Čisti dobiček pred dodatnimi postavkami | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
| Čisti dobiček | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
| Popravljen čisti dobiček | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
| Popravljene ponderirane povprečne delnice | 139.579 | 86.1451 | 54.3481 | 45.1889 | 22.896 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.51331 | -0.87931 | -0.88833 | -1.45486 | -1.9112 |
| Popravljen normalizirani dobiček na enoto čistega dobička | -0.51331 | -0.89083 | -0.91713 | -1.45486 | -1.82142 |
| Depreciation / Amortization | 0.71535 | 0.71535 | 0.84494 | 0.84494 | 1.23467 |
| Skupaj izredne postavke | 0 | ||||
| Gain (Loss) on Sale of Assets | 0 | 11.5274 |
| Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | |
|---|---|---|---|---|---|
| Skupni prihodki | 41.0901 | 33.905 | 29.1031 | 26.3829 | 20.6805 |
| Prihodki | 41.0901 | 33.905 | 29.1031 | 26.3829 | 20.6805 |
| Celotni stroški prihodkov | 31.4335 | 26.1356 | 25.441 | 22.8714 | 20.2952 |
| Bruto dobiček | 9.65664 | 7.7694 | 3.66204 | 3.51149 | 0.38534 |
| Celotni odhodki iz poslovanja | 50.4069 | 43.0798 | 50.5881 | 39.5741 | 35.1176 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 17.7526 | 15.8919 | 17.6742 | 15.7948 | 13.873 |
| Raziskave in razvoj | 1.04195 | 0.87339 | 0.62411 | 0.72899 | 0.77056 |
| Depreciation / Amortization | 0.17884 | 0.17884 | 0.17884 | 0.17884 | 0.17884 |
| Prihodki iz poslovanja | -9.31673 | -9.17474 | -21.485 | -13.1912 | -14.4371 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -5.57313 | -4.57075 | -3.35597 | -3.31343 | -3.29442 |
| Drugo, neto | -0.00964 | -0.01942 | -0.16688 | -0.1448 | 0.01855 |
| Čisti dobiček pred obdavčitvijo | -14.8995 | -13.7649 | -25.0079 | -16.6494 | -17.7129 |
| Čisti dobiček po davkih | -14.8995 | -13.7649 | -25.0079 | -16.6494 | -17.7129 |
| Čisti dobiček pred dodatnimi postavkami | -14.8995 | -13.7649 | -25.0079 | -16.6494 | -17.7129 |
| Čisti dobiček | -14.8995 | -13.7649 | -25.0079 | -16.6494 | -17.7129 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -14.8995 | -13.7649 | -25.0079 | -16.6494 | -17.7129 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -14.8995 | -13.7649 | -25.0079 | -16.6494 | -17.7129 |
| Popravljen čisti dobiček | -14.8995 | -13.7649 | -25.0079 | -16.6494 | -17.7129 |
| Popravljene ponderirane povprečne delnice | 196.384 | 196.353 | 195.872 | 181.267 | 133.77 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.07587 | -0.0701 | -0.12767 | -0.09185 | -0.13241 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Popravljen normalizirani dobiček na enoto čistega dobička | -0.07587 | -0.0701 | -0.09362 | -0.09185 | -0.13241 |
| Nenavadni odhodki (prihodki) | 0 | 0 | 6.66994 | 0 |
- Letni
- Četrtletno
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 208.729 | 153.741 | 85.8204 | 44.5296 | 62.3416 |
| Denarna sredstva in kratkoročne naložbe | 51.0891 | 55.9212 | 26.7521 | 22.7549 | 43.1076 |
| Denarna sredstva in ustrezniki | 51.0891 | 55.9212 | 26.7521 | 22.7549 | 43.1076 |
| Kratkoročne naložbe | |||||
| Celotne terjatve, neto | 28.5769 | 13.2373 | 3.46992 | 1.39244 | 3.88015 |
| Accounts Receivable - Trade, Net | 28.5769 | 13.2373 | 3.46992 | 1.39244 | 3.88015 |
| Total Inventory | 124.724 | 81.5356 | 53.0647 | 18.6162 | 12.6282 |
| Prepaid Expenses | 4.33925 | 3.04647 | 2.53359 | 1.76616 | 1.22565 |
| Total Assets | 276.253 | 207.673 | 127.091 | 88.8765 | 108.019 |
| Property/Plant/Equipment, Total - Net | 58.1977 | 45.8523 | 33.1413 | 30.1157 | 30.4669 |
| Property/Plant/Equipment, Total - Gross | 71.4696 | 54.7162 | 38.8663 | 33.5368 | 31.7528 |
| Accumulated Depreciation, Total | -13.2718 | -8.86394 | -5.72496 | -3.42103 | -1.28592 |
| Other Long Term Assets, Total | 4.0674 | 2.10698 | 1.44004 | 6.69725 | 6.83155 |
| Total Current Liabilities | 30.3783 | 19.9474 | 14.0279 | 9.62505 | 9.44018 |
| Accounts Payable | 12.4294 | 11.0737 | 9.17459 | 5.90039 | 5.92087 |
| Accrued Expenses | 16.7941 | 8.73083 | 4.71047 | 3.58182 | 3.37648 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | |||||
| Other Current Liabilities, Total | 1.15482 | 0.14283 | 0.14283 | 0.14283 | 0.14283 |
| Total Liabilities | 135.08 | 119.424 | 100.898 | 69.1061 | 67.6861 |
| Total Long Term Debt | 94.8662 | 92.9689 | 83.1992 | 44.075 | 42.9709 |
| Long Term Debt | 94.8662 | 92.9689 | 83.1992 | 44.075 | 42.9709 |
| Other Liabilities, Total | 9.8356 | 6.50774 | 3.67047 | 15.406 | 15.275 |
| Total Equity | 141.173 | 88.2494 | 26.1931 | 19.7704 | 40.3328 |
| Common Stock | 0.01958 | 0.01049 | 0.00593 | 0.00464 | 0.00453 |
| Additional Paid-In Capital | 553.266 | 428.704 | 290.904 | 236.203 | 191.022 |
| Retained Earnings (Accumulated Deficit) | -412.113 | -340.465 | -264.717 | -216.437 | -150.694 |
| Total Liabilities & Shareholders’ Equity | 276.253 | 207.673 | 127.091 | 88.8765 | 108.019 |
| Total Common Shares Outstanding | 195.814 | 104.903 | 59.3184 | 46.3531 | 36.7255 |
| Other Current Assets, Total | 0 | 1.5 | |||
| Goodwill, Net | 3.52951 | 3.52951 | 3.52951 | 3.52951 | 3.52951 |
| Intangibles, Net | 1.72877 | 2.44412 | 3.15947 | 4.00441 | 4.84935 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 239.8 | 208.729 | 174.785 | 171.355 | 177.277 |
| Denarna sredstva in kratkoročne naložbe | 69.505 | 51.0891 | 34.4106 | 42.409 | 61.9657 |
| Denarna sredstva in ustrezniki | 69.505 | 51.0891 | 34.4106 | 42.409 | 61.9657 |
| Celotne terjatve, neto | 25.6296 | 28.5769 | 20.3926 | 23.5446 | 15.362 |
| Accounts Receivable - Trade, Net | 25.6296 | 28.5769 | 20.3926 | 23.5446 | 15.362 |
| Total Inventory | 139.146 | 124.724 | 114.123 | 99.6997 | 94.1462 |
| Prepaid Expenses | 5.5193 | 4.33925 | 5.85905 | 5.70186 | 5.80261 |
| Total Assets | 308.033 | 276.253 | 238.64 | 232.814 | 235.667 |
| Property/Plant/Equipment, Total - Net | 60.3271 | 58.1977 | 55.0847 | 53.316 | 50.3729 |
| Property/Plant/Equipment, Total - Gross | 75.0076 | 71.4696 | 67.2809 | 64.2715 | 60.2769 |
| Accumulated Depreciation, Total | -14.6804 | -13.2718 | -12.1962 | -10.9555 | -9.90401 |
| Goodwill, Net | 3.52951 | 3.52951 | 3.52951 | 3.52951 | 3.52951 |
| Intangibles, Net | 1.54993 | 1.72877 | 1.90761 | 2.08645 | 2.26528 |
| Other Long Term Assets, Total | 2.82575 | 4.0674 | 3.33351 | 2.52666 | 2.22278 |
| Total Current Liabilities | 31.5665 | 30.3783 | 32.3372 | 18.1864 | 21.2057 |
| Accounts Payable | 14.1151 | 12.4294 | 17.2828 | 6.16747 | 12.1529 |
| Accrued Expenses | 14.2198 | 16.7941 | 13.0301 | 10.7303 | 8.14151 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 3.23159 | 1.15482 | 2.02432 | 1.28866 | 0.91137 |
| Total Liabilities | 181.099 | 135.08 | 135.86 | 121.22 | 123.163 |
| Total Long Term Debt | 138.423 | 94.8662 | 94.363 | 93.877 | 93.4127 |
| Long Term Debt | 138.423 | 94.8662 | 94.363 | 93.877 | 93.4127 |
| Other Liabilities, Total | 11.1099 | 9.8356 | 9.15999 | 9.15685 | 8.54454 |
| Total Equity | 126.933 | 141.173 | 102.78 | 111.594 | 112.504 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 0.01964 | 0.01958 | 0.01383 | 0.01319 | 0.0123 |
| Additional Paid-In Capital | 564.034 | 553.266 | 498.23 | 489.331 | 471.337 |
| Retained Earnings (Accumulated Deficit) | -437.121 | -412.113 | -395.463 | -377.75 | -358.845 |
| Total Liabilities & Shareholders’ Equity | 308.033 | 276.253 | 238.64 | 232.814 | 235.667 |
| Total Common Shares Outstanding | 196.348 | 195.814 | 138.314 | 131.872 | 123.045 |
- Letni
- Četrtletno
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Čisti prihodki/začetna postavka | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
| Denarna sredstva iz poslovanja | -112.369 | -102.003 | -76.1935 | -62.6787 | -37.2718 |
| Denarna sredstva iz poslovanja | 5.4955 | 3.94229 | 3.25815 | 3.4464 | 2.6923 |
| Nedenarne postavke | 5.46355 | 3.58462 | 2.33044 | 3.30681 | 4.07714 |
| Denarna sredstva Plačane obresti | 11.1595 | 10.2676 | 8.11223 | 4.39997 | 2.29359 |
| Spremembe v obratnem kapitalu | -51.6804 | -33.7813 | -33.5028 | -3.68844 | -0.28224 |
| Denarna sredstva pri naložbenju | -13.5113 | -12.7247 | -3.81184 | -2.0956 | 15.2139 |
| Kapitalski izdatki | -13.5113 | -12.7267 | -3.81184 | -2.0956 | -2.67633 |
| Celotne druge postavke denarnih tokov pri naložbenju | 0 | 0.002 | 0 | 17.8902 | |
| Denarna sredstva pri financiranju | 121.048 | 143.897 | 80.0026 | 42.9216 | 60.7506 |
| Postavke denarnega toka pri financiranju | -0.0616 | -0.83 | -10.9395 | 0 | -3.44017 |
| Izdaja (odplačilo) delnic, neto | 121.144 | 131.209 | 48.4721 | 42.9578 | 39.2074 |
| Izdaja (odplačilo) dolga, neto | -0.0343 | 13.5179 | 42.47 | -0.03628 | 24.9834 |
| Neto sprememba denarnih sredstev | -4.83203 | 29.169 | -0.00272 | -21.8527 | 38.6927 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -25.0079 | -71.6476 | -54.9982 | -37.2852 | -18.3799 |
| Cash From Operating Activities | -26.0134 | -112.369 | -78.9037 | -65.4914 | -33.2291 |
| Cash From Operating Activities | 1.59022 | 5.4955 | 3.97779 | 2.55562 | 1.22963 |
| Non-Cash Items | 8.86246 | 5.46355 | 3.64236 | 2.50146 | 1.19026 |
| Cash Interest Paid | 2.52599 | 11.1595 | 8.34697 | 5.53428 | 2.75196 |
| Changes in Working Capital | -11.4582 | -51.6804 | -31.5257 | -33.2632 | -17.2691 |
| Cash From Investing Activities | -2.84209 | -13.5113 | -9.8354 | -7.04674 | -2.57116 |
| Capital Expenditures | -2.84209 | -13.5113 | -9.8354 | -7.04674 | -2.57116 |
| Other Investing Cash Flow Items, Total | 0 | 0 | 0 | 0 | |
| Cash From Financing Activities | 47.2713 | 121.048 | 67.2286 | 59.0259 | 41.8448 |
| Financing Cash Flow Items | -4.46973 | -0.0616 | -0.0616 | -0.05931 | -0.05931 |
| Issuance (Retirement) of Stock, Net | 0 | 121.144 | 67.3157 | 59.1021 | 41.9125 |
| Issuance (Retirement) of Debt, Net | 51.7411 | -0.0343 | -0.02551 | -0.01686 | -0.00836 |
| Net Change in Cash | 18.4158 | -4.83203 | -21.5106 | -13.5122 | 6.04456 |
| Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
|---|---|---|---|---|---|---|
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.1941 | 13488055 | 1946140 | 2022-12-31 | LOW |
| Perceptive Advisors LLC | Private Equity | 5.465 | 11900255 | 966868 | 2022-12-31 | MED |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 5.0548 | 11007209 | 1583787 | 2022-12-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.9762 | 10835875 | 1545176 | 2022-12-31 | LOW |
| NWQ Investment Management Company, LLC | Investment Advisor/Hedge Fund | 4.8736 | 10612600 | 3727960 | 2021-12-31 | LOW |
| D. E. Shaw & Co., L.P. | Hedge Fund | 3.9073 | 8508409 | 2664613 | 2022-12-31 | MED |
| Stonepine Capital Management, LLC | Investment Advisor/Hedge Fund | 3.1871 | 6940000 | 1940000 | 2022-12-31 | MED |
| Magnetar Capital Partners LP | Investment Advisor/Hedge Fund | 2.8414 | 6187316 | 1815908 | 2022-12-31 | HIGH |
| AWM Investment Company, Inc. | Investment Advisor/Hedge Fund | 2.7623 | 6015000 | 1000000 | 2022-12-31 | LOW |
| Millennium Management LLC | Hedge Fund | 2.4324 | 5296781 | 3569778 | 2022-12-31 | HIGH |
| Nuveen Asset Management, LLC | Investment Advisor/Hedge Fund | 1.8845 | 4103514 | -883582 | 2022-12-31 | LOW |
| Velan Capital Investment Management LP | Investment Advisor/Hedge Fund | 1.8369 | 4000000 | -1269155 | 2022-12-31 | MED |
| Invesco Advisers, Inc. | Investment Advisor | 1.7886 | 3894678 | 813693 | 2022-12-31 | LOW |
| Aisling Capital, LLC | Private Equity | 1.6604 | 3615671 | 0 | 2022-04-15 | |
| Nuveen LLC | Pension Fund | 1.5839 | 3448993 | -267644 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.5553 | 3386852 | 100723 | 2022-12-31 | LOW |
| Two Sigma Investments, LP | Hedge Fund | 1.364 | 2970124 | 1530127 | 2022-12-31 | HIGH |
| Altium Capital Management LP | Investment Advisor/Hedge Fund | 1.318 | 2870000 | -13710 | 2022-12-31 | HIGH |
| Morgan Stanley & Co. LLC | Research Firm | 1.2959 | 2821903 | 558990 | 2022-12-31 | MED |
| Caligan Partners, LP | Hedge Fund | 1.2289 | 2676093 | -8217144 | 2022-12-31 | MED |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group500K+
Borzni posredniki
92K+
Aktivne stranke mesečno
$53M+
Mesečni obseg naložb
$30M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
Trgovalna provizija
0
- 1:1
Vzvod
1:1
- 20
- 100
- 500
- 1000
- 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje
Zapiranje
Kratka Dolga
ADMA Biologics, Inc. Company profile
O družbi ADMA Biologics, Inc.
ADMA Biologics, Inc. je biofarmacevtsko podjetje. Razvija, proizvaja in trži posebna biološka zdravila na osnovi plazme za zdravljenje in preprečevanje nalezljivih bolezni. Ukvarja se z razvojem in trženjem človeške plazme in zdravil, pridobljenih iz plazme. Njegovi bolniki so imunsko oslabljeni posamezniki, ki trpijo zaradi osnovne motnje imunske pomanjkljivosti in so zaradi zdravstvenih razlogov imunsko oslabljeni. Njeni kandidati za izdelke vključujejo BIVIGAM, intravenski imunski globulin (IVIG) za zdravljenje primarne humoralne imunske pomanjkljivosti (PI); ASCENIV, IVIG za zdravljenje PI, in Nabi-HB za zdravljenje akutne izpostavljenosti krvi, ki vsebuje površinski antigen hepatitisa B (HBsAg). Njena hčerinska družba ADMA BioCenters upravlja objekte za zbiranje izvorne plazme v Združenih državah Amerike. Njen segment Plasma Collection Centers zagotavlja del svoje krvne plazme za proizvodnjo kandidatnih izdelkov.
| Industry: | Biopharmaceuticals |
C/O Adma Biologics, Inc.
465 State Route 17
07446
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com